Founded in 1990 and based in Dublin, Ireland, ICON plc operates as a global leader in the contract research organization (CRO) industry. The company offers a broad spectrum of drug development solutions, including clinical trial management, medical imaging, laboratory services, and regulatory consulting. ICON serves a diverse client base that includes large pharmaceutical firms, biotechnology companies, medical device manufacturers, and public health organizations. Its operations span over 50 countries, supported by a workforce of approximately 40,000 employees. The company significantly expanded its scale and capabilities through the $12 billion acquisition of PRA Health Sciences in 2021, solidifying its competitive position as one of the world's largest clinical research partners.
